Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

AICrypto BriefingFiled 49 min ago

Isomorphic Labs raises $5 billion in Series C to push AI-designed drugs toward clinical trials

Open the sourceReported by Crypto Briefing, cryptobriefing.com, 17 November 2026, by Diego Almada Lopez

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Isomorphic Labs has raised $5 billion in a Series C round to advance its AI-designed drug candidates toward clinical trials. The London-based company, spun out of Google DeepMind, said the capital will fund preclinical work and early-stage human testing across its pipeline of computationally designed therapeutics. The raise ranks among the largest private financings for an AI-native biotech and signals continued investor appetite for applying machine learning to cut drug discovery timelines and costs. The company has not disclosed specific program timelines or which candidates will enter trials first. Watch for the first investigational new drug filings and any partnership or milestone disclosures that validate its preclinical predictions.

Muhabbit's AI wrote this summary in its own words from Crypto Briefing's report. It can get details wrong, so check the source.

Named in this story

Isomorphic Labs